No ordinary affair. IAS 2017 report from Paris, Part One: Conference highlights

Bob Leahy was in Paris last week covering the big IAS conference on HIV Science. Turns out it was the best he had been to and not just because Undetectable=Untransmittable (U=U) almost stole the show. Here is what else happened.

International AIDS Society Conferences come in two sizes. They alternate. Next year will be the big one in Amsterdam which deals with the whole panoply of HIV knowledge, including science and research and more. It will likely attract about 20,000 people.

This year’s alternate year conference was just about HIV science, a smaller affair with 8,000 or so of us in attendance from 40 countries with an agenda less community-based. In other words, it was potentially a bit dull. This one certainly wasn’t. The IAS themselves called it “an extraordinary week”. And for those like me, working in the Undetectable = Untransmittable campaign, it was intensely exciting, affirming of the role of people living with HIV in the response to the epidemic – and euphoric. More on that in Part Two.

I was privileged to be there. It’s important for us who, by hook or by crook, got to go to Paris – some of us paying our own way, some not – to acknowledge we are the lucky ones. We work like dogs there though. We seldom rest. We come home exhausted.

We also saw – and proved it ourselves – that activism is far from dead. Interruptions and protests during plenary sessions were commonplace. The people in U=U t-shirts were everywhere; many observers I spoke to acknowledged that U=U was a dominant theme, that we “owned” the conference. People saw the mainstreaming of the work of grass roots activists bloom in front of them – our work – like a rare and exotic flower. And they applauded.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below